Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Dimitri E. Grigoriadis0
Date of Patent
February 2, 2021
Patent Application Number
16227127
Date Filed
December 20, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
CRF1 receptor antagonists have the potential to directly inhibit ACTH release in patients with CAH and thereby allow normalization of androgen production while using lower, more physiologic doses of hydrocortisone, and thus reducing treatment-associated side effects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
